title: In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy.
authors.forename: Piernicola
authors.initials: P
authors.lastname: Pedicini
authors.forename: Rocchina
authors.initials: R
authors.lastname: Caivano
authors.forename: Lidia
authors.initials: L
authors.lastname: Strigari
authors.forename: Marcello
authors.initials: M
authors.lastname: Benassi
authors.forename: Alba
authors.initials: A
authors.lastname: Fiorentino
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Fusco
mesh_terms: D016208:Databases, Factual / Q000706:statistics & numerical data*; D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011836:Radiation Tolerance